Macrovision Therapy

Vision increase can be achieved in patients with macular degeneration through a specially designed dual-focus intraocular lens with a central optical field providing + 10.0D insertion power. Thanks to this operation, it can be easily applied with the lens structure that can be placed on the existing lens in patients who have had cataract surgery and with intraocular lenses.

To whom is macrovision treatment recommended?

It only targets patients with advanced dry-type macular degeneration, who have an intraocular lens attached, and offers a convenient, simple and safe solution to treat their distorted close vision due to macular degeneration.

Macrovision focuses on advanced SMD patients, but it may also be useful for patients with other macular diseases, for example myopic maculopathy, diabetic maculopathy or hereditary retinal diseases.

Two-thirds of patients with advanced SMD and visual acuity of 0.3 or less have already had intraocular lenses due to cataract surgery – these patients can benefit from macrovision.

The operation can be performed simultaneously with cataract operation, but preferably cataract surgery should be done first. After a repeated visual acuity test after surgery, macrovision therapy can be continued if the patient is still dissatisfied.